Grantham, Mayo, Van Otterloo & Co (GMO)’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-729,700
| Closed | -$72.5M | – | 811 |
|
|
2019
Q3 | $72.5M | Sell |
729,700
-27,700
| -4% | -$2.75M | 0.5% | 41 |
|
|
2019
Q2 | $70M | Buy |
757,400
+751,800
| +13,425% | +$69.5M | 0.49% | 48 |
|
|
2019
Q1 | $528K | Buy |
+5,600
| New | +$528K | ﹤0.01% | 574 |
|
|
2017
Q4 | – | Sell |
-2,700
| Closed | -$394K | – | 643 |
|
|
2017
Q3 | $394K | Sell |
2,700
-300
| -10% | -$43.8K | ﹤0.01% | 415 |
|
|
2017
Q2 | $390K | Buy |
3,000
+1,100
| +58% | +$143K | ﹤0.01% | 408 |
|
|
2017
Q1 | $236K | Buy |
+1,900
| New | +$236K | ﹤0.01% | 458 |
|
|
2014
Q3 | – | Sell |
-50,000
| Closed | -$4.29M | – | 533 |
|
|
2014
Q2 | $4.29M | Sell |
50,000
-18,200
| -27% | -$1.56M | 0.01% | 290 |
|
|
2014
Q1 | $4.76M | Sell |
68,200
-105,644
| -61% | -$7.37M | 0.01% | 307 |
|
|
2013
Q4 | $14.7M | Sell |
173,844
-101,380
| -37% | -$8.56M | 0.04% | 173 |
|
|
2013
Q3 | $21.2M | Buy |
275,224
+70,246
| +34% | +$5.41M | 0.06% | 138 |
|
|
2013
Q2 | $12M | Buy |
+204,978
| New | +$12M | 0.03% | 188 |
|